NewsIn memory
Tim Curry's Death Certificate Listed Kidney Cancer: What That Means
Tim Curry died of coronary artery disease at 80, with kidney cancer and stroke listed as contributing conditions. What kidney cancer's early signs are, why there is no screening test, and what federal sources actually say.
Original commentary from the Cancer Explained editorial team.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
What the record says
Tim Curry died at his home in Los Angeles on August 25, 2026, at 80. He was Dr Frank-N-Furter in "The Rocky Horror Picture Show." He was Pennywise in the 1990 television version of "It," Rooster in "Annie," and the concierge in "Home Alone 2."
On September 2, his spokesman confirmed the cause of death to the BBC. It was coronary artery disease. The spokesman cited the death certificate filed in Los Angeles County. It listed a history of stroke and kidney cancer as significant conditions that contributed to the death. TMZ reported the same details the same day.
Curry had a near-fatal stroke in 2012 and used a wheelchair afterwards. He moved his work to voice acting. He wrote about that recovery in his memoir last year.
Nothing about his kidney cancer had been public before the certificate. Not when it was found. Not its stage. Not what treatment he had. None of that is in the record, and none of it belongs on this page as guesswork.
"Contributing condition" is a specific phrase
A US death certificate does not ask for one cause. It asks for the immediate cause, and for the chain of events that led to it. Then, separately, it asks for other significant conditions that contributed to the death without causing that chain.
Coronary artery disease was on the first list. Kidney cancer and stroke were on the second.
That difference matters for reading the news accurately. It does not say cancer killed him. It does not say the cancer was beside the point. It says a clinician judged that these conditions made him more likely to die when he did, without being the mechanism.
Someone with cancer, a stroke history, and narrowed heart arteries at 80 has less reserve for any one of them. That is what the second list is for.
CDC calls coronary artery disease the most common form of heart disease in the United States. Plaque builds up inside the arteries of the heart and narrows them. That can cause chest pain, a heart attack, and in time heart failure.
Kidney cancer, in plain terms
The kidneys sit at the back of the abdomen, about level with the lowest ribs. They filter blood and make urine.
NCI names three main types of kidney cancer. Renal cell cancer. Transitional cell cancer of the renal pelvis or ureter. And Wilms tumor, which is a childhood cancer.
Renal cell cancer is by far the most common in adults. It starts in the small tubes that do the filtering.
The early signs, and why they usually arrive late
NCI is blunt about the beginning. Early kidney cancer often causes no symptoms at all.
When signs do appear, the two most typical are blood in the urine and a lump in the abdomen or side. The others on NCI's list are easy to blame on something else:
- Pain in the side or lower back that does not go away
- Loss of appetite
- Weight loss with no clear reason
- Anemia
Each of these has ordinary causes that are not cancer. What makes them worth a doctor's attention is that they last, or that several arrive together. Blood in the urine is worth reporting the first time, even once, even if it clears.
A kidney can grow a tumor for a long time without pressing on anything that hurts. There is no place a doctor can feel it on a routine exam. So a large share of kidney cancers are found by accident, on a scan ordered for something else.
Why there is no screening test
This is the part most coverage skips.
NCI's kidney cancer hub says plainly that NCI does not have evidence-based information about screening for kidney cancer. It says the same about prevention. There is no federal screening recommendation for kidney cancer in people at average risk, the way there is for breast, colorectal, cervical, and lung cancer.
That is not an oversight. Screening a whole population only helps if the test is accurate enough, and if finding the disease earlier changes enough outcomes. It has to be worth the false alarms and the procedures they trigger. That case has not been made for kidney cancer in average-risk adults.
People with a known inherited syndrome are in a different situation. NCI lists von Hippel-Lindau disease and hereditary papillary renal cancer among the inherited conditions that raise risk. People with those diagnoses are usually followed with regular imaging at a specialist center. That is a plan made with a care team, not a general recommendation.
What actually lowers risk
NCI's list of risk factors separates what a person can change from what they cannot.
Changeable: smoking, and long-term misuse of certain over-the-counter pain medicines. Excess weight and high blood pressure are also on the list, and both are treatable.
Fixed: increasing age, a family history of kidney cancer, and the inherited syndromes above.
The overlap with heart disease is not a coincidence. Smoking, excess weight, inactivity, and untreated high blood pressure all appear on CDC's list for coronary artery disease and on NCI's list for kidney cancer. Addressing them is no guarantee against either disease. It is simply the same short list of things that shifts the odds on both.
What treatment looks like now
For cancer still inside the kidney, surgery is the mainstay. That means removing the tumor, or part or all of the kidney. NCI also describes ablation methods, including cryotherapy and radiofrequency ablation, for people who cannot have surgery.
Advanced kidney cancer is one of the areas where the drug landscape changed most in twenty years. NCI's patient summary lists immunotherapy options including nivolumab, pembrolizumab, ipilimumab, avelumab, interleukin-2, and interferon. It lists targeted therapies including axitinib, cabozantinib, lenvatinib, pazopanib, sunitinib, sorafenib, tivozanib, everolimus, temsirolimus, and bevacizumab.
The FDA approved belzutifan on December 14, 2023. The approval covers advanced renal cell carcinoma after a PD-1 or PD-L1 inhibitor and a VEGF tyrosine kinase inhibitor. It was based on the LITESPARK-005 trial. Progression-free survival improved against everolimus, with a hazard ratio of 0.75. Overall survival data were immature at that analysis, with no harm observed.
That is a real approval, and a modest, specific benefit for a specific line of treatment. It is worth reading that way rather than as a breakthrough.
The numbers, and what they do not say
Two different bodies produce the figures below, and it is worth keeping them apart. The calendar-year forecasts are projections by the American Cancer Society, published on NCI's SEER pages. Everything else is NCI's own measurement.
The American Cancer Society projected 80,980 new cases of kidney and renal pelvis cancer in the United States for 2025, and 14,510 deaths.
From NCI's own SEER measurements:
- The seventh most common cancer, about 4.0 percent of all new cancer diagnoses
- 65.7 percent are found while still confined to the kidney
- Five-year relative survival: 93.3 percent for localized disease, 76.4 percent for regional, 19.1 percent for distant
- Age-adjusted death rates fell an average of 1.4 percent per year from 2014 through 2023
These are group averages, drawn from people diagnosed years ago, under treatments that have since changed. They describe populations. They do not describe any individual, and they cannot be applied to one.
What this story cannot tell you
- The certificate names kidney cancer as a contributing condition. It does not give the type, the stage, when it was found, or how it was treated. No honest account can add those.
- Coronary artery disease was the cause of death. Reading the story as "died of cancer" misreads the document. So does reading it as "cancer had nothing to do with it."
- A stroke history and heart disease are not caused by kidney cancer, and kidney cancer is not caused by them. They shared a patient, not a mechanism.
- Blood in the urine, side pain, and unexplained weight loss have many ordinary explanations. Persistence is what makes them worth checking.
- Nothing here is medical advice, a diagnosis, or a reason to change your own care. If any of these signs apply to you, the next step is a conversation with a clinician, not a search engine.
Sources
- BBC News, Sept. 2, 2026: Rocky Horror star Tim Curry's cause of death revealed as coronary artery disease
- TMZ, Sept. 2, 2026: Tim Curry's cause of death
- National Cancer Institute: Kidney Cancer—Patient Version
- NCI PDQ: Renal Cell Cancer Treatment—Patient Version
- NCI SEER Cancer Stat Facts: Kidney and Renal Pelvis Cancer
- FDA: FDA approves belzutifan for advanced renal cell carcinoma, December 14, 2023
- CDC: About Coronary Artery Disease
How this page was made
An AI-assisted editorial system helped prepare this page. This article has not been reviewed by a healthcare professional unless a named reviewer is specifically shown. Cancer Explained is published by the National Cancer Information Foundation as a nonprofit-oriented public-interest education project. It is not a diagnostic service, does not recommend treatments, and is not for emergencies.
See an error, old source, or unclear wording? Tell us.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to Kidney cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
Learn about this story’s cancer topic
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.